interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Citric Acid; Magnesium Oxide; Sodium Picosulfate

Generic competition · all medicines · read 12 November 2026

Is there a generic of Citric Acid; Magnesium Oxide; Sodium Picosulfate, and who makes it?

Citric Acid; Magnesium Oxide; Sodium Picosulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 10 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Citric Acid; Magnesium Oxide; Sodium Picosulfate2 dosage-form groups in the Orange Book
1generic maker listed
  1. Citric Acid; Magnesium Oxide; Sodium Picosulfate appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 10 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

For Solution, Oral

One to three generic makers listed

Every brand product here is listed as discontinued. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 18 July 2022.

2010201520202025203001brand 2012Hetero Labs Ltd Unit V, first approval 18 July 2022data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Hetero Labs Ltd Unit V18 July 20221

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Clenpiq. No generic is listed as marketed.

20152020202520302035204001brand 2017data datePatent 11191753 listed to expire 23 June 2034Patent 12576072 listed to expire 23 June 2034Patent 10624879 listed to expire 23 June 2034Patent 9827231 listed to expire 26 June 2034Patent 12458634 listed to expire 27 January 2038
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 23 June 2034Patent 11191753
  • 23 June 2034Patent 12576072 drug product
  • 23 June 2034Patent 10624879 drug product
  • 26 June 2034Patent 9827231 drug product
  • 27 January 2038Patent 12458634 drug product

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.